Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Heng Lungh Choo"'
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 64K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26c0e9465ad4a531af2ba888341fb366
https://doi.org/10.1158/1535-7163.22496415.v1
https://doi.org/10.1158/1535-7163.22496415.v1
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 569K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74a6bf280570d8fd314b8501dcde481
https://doi.org/10.1158/1535-7163.22496412
https://doi.org/10.1158/1535-7163.22496412
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F-203; NSC 703786) and 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610; NSC 721648) are antitumor agents with novel mechanism(s). Previous studies have indicated that cytochrome (CYP) P450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26d3d3106604927bfb2cf8eff32dc1c6
https://doi.org/10.1158/1535-7163.c.6535263.v1
https://doi.org/10.1158/1535-7163.c.6535263.v1
Autor:
Chee-Onn Leong, Malcolm F.G. Stevens, Tracey D. Bradshaw, Heng Lungh Choo, Nirmal Randhawa, Ashwin Muruhadas, Kai Hung Tiong, Boon Shing Tan
PDF file - 55K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::500294b0165133573b96dfd839e8e6b5
https://doi.org/10.1158/1535-7163.22496409.v1
https://doi.org/10.1158/1535-7163.22496409.v1
Autor:
Felicia Fei-Lei Chung, Yuen-Fen Tan, Si Hoey Tan, Kai Hung Tiong, Chee-Onn Leong, Nelson Tze Woei Khor, Soon Keng Cheong, Rozita Rosli, Shew Fung Wong, Heng Lungh Choo, Sze-Jia See, Ling-Wei Hii, Boon Shing Tan
Publikováno v:
Oncotarget
// Kai Hung Tiong 1, 2, 3 , Boon Shing Tan 1, 4 , Heng Lungh Choo 1, 5 , Felicia Fei-Lei Chung 5 , Ling-Wei Hii 1, 5 , Si Hoey Tan 1, 5 , Nelson Tze Woei Khor 6 , Shew Fung Wong 7 , Sze-Jia See 5 , Yuen-Fen Tan 1, 5 , Rozita Rosli 8 , Soon-Keng Cheon
Autor:
Nirmal Randhawa, Chee-Onn Leong, Ashwin Muruhadas, Tracey D. Bradshaw, Heng Lungh Choo, Malcolm F. G. Stevens, Boon Shing Tan, Kai Hung Tiong
Publikováno v:
Molecular Cancer Therapeutics. 10:1982-1992
Both 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F-203; NSC 703786) and 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610; NSC 721648) are antitumor agents with novel mechanism(s). Previous studies have indicated that cytochrome (CYP) P450
Autor:
Weng Yip Kong, Yuen Chee Yue, Rozita Rosli, Soon Keng Cheong, Irene So, Kai Hung Tiong, Cyril Chung, Choon Hooi Chua, Heng Lungh Choo, Boon Shing Tan, Su Wei Wong, Jae Ying Lim, Sean I. Quah, Chai Yuin Lee, Cindy Fow, Chee-Onn Leong
Publikováno v:
Breast Cancer Research and Treatment. 128:301-313
Recent gene expression profiling studies have identified five breast cancer subtypes, of which the basal-like subtype is the most aggressive. Basal-like breast cancer poses serious clinical challenges as there are currently no targeted therapies avai
Publikováno v:
Journal of oralfacial pain and headache. 28(4)
To carry out a pilot study to test the hypothesis that human herpes virus-6 (HHV-6) infection or reactivation plays a role in the pathogenesis of temporomandibular disorders (TMD) of muscular origin (ie, localized myalgia).Sixteen patients with local
Autor:
Kai Hung Tiong, Chee-Onn Leong, Alan Soo-Beng Khoo, Boon Shing Tan, Heng Lungh Choo, Soon Yang Low
Publikováno v:
Cancer letters. 314(2)
The efficacy of cisplatin for treating nasopharyngeal carcinoma (NPC) is limited by the dose-related toxicities and the development of resistance to cisplatin. Recent studies have shown that B cell lymphoma-2 (BCL-2) is overexpressed and confers chem
Autor:
C-O Leong, Heng Lungh Choo, Shew Fung Wong, L-W Hii, K H Tiong, Felicia Fei-Lei Chung, N Tw Khor, Boon Shing Tan, Rozita Rosli, I Ks Yap, S-K Cheong, Si Hoey Tan, S Pani
Publikováno v:
Cell Death & Disease
p53 is the most frequently mutated tumor-suppressor gene in human cancers. Unlike other tumor-suppressor genes, p53 mutations mainly occur as missense mutations within the DNA-binding domain, leading to the expression of full-length mutant p53 protei